Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder

Neuropsychopharmacology

Volumn 30, Issue 6, 2005, Pages 1163-1172

  Oquendo, Maria A ^a,b   Krunic, Aleksandra ^a   Parsey, Ramin V ^a,b   Milak, Matthew ^a,b   Malone, Kevin M ^b   Anderson, Amy ^b   Van Heertum, Ronald L ^a,b   Mann, J John ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Borderline personality disorder; Comorbidity; Depressive disorder; Fenfluramine; Major; Positron emission tomography; Serotonin

Indexed keywords

FENFLURAMINE; FLUORODEOXYGLUCOSE; GLUCOSE; PLACEBO; PROLACTIN;

ADULT; ARTICLE; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DRUG BRAIN LEVEL; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL CORTEX; GLUCOSE TRANSPORT; HOSTILITY; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; PARIETAL LOBE; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TEMPORAL CORTEX;

ADULT; AGGRESSION; BORDERLINE PERSONALITY DISORDER; BRAIN CHEMISTRY; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FEMALE; FENFLURAMINE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HOSTILITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMPULSIVE BEHAVIOR; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; SEROTONIN; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS;

EID: 19344375680     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300689     Document Type: Article

References (60)

1. Asberg M (1997). Neurotransmitters and suicidal behavior: the evidence from cerebrospinal fluid studies. Ann NY Acad Sci 836: 158-181.
2. 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 26: 31-43.
3. Barratt ES (1965). Factor analysis of some psychometric measures of impulsiveness and anxiety. Psycholog Rep 16: 547-554.
4. Baxter Jr. LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243-250.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63.
6. Bench CJ, Frackowiak RSJ, Dolan RJ (1995). Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25: 247-261.
7. Biver F, Goldman S, Delvenne V, Luxen A, DeMaertelaer V, Hubain P et al (1994). Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 36: 381-388.
8. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL et al (1997). Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54: 364-374.
9. Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME et al (1999). Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiat Res 91: 127-139.
10. Bromfield EB, Altshuler L, Leiderman DB, Balish M, Ketter TA, Devinsky O et al (1992). Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol 49: 617-623.
11. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979). Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1: 131-139.
12. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L et al (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41: 15-22.
13. Bunce SC, Coccaro E (1999). Factors differentiating personality- disordered individuals with and without a history of unipolar mood disorder. Depress Anxiety 10: 147-157.
14. Buss AH, Durkee A (1957). An inventory for assessing different kinds of hostility. J Consult Psychol 21: 343-349.
15. Butter CM, Snyder DR, McDonald JA (1970). Effects of orbital frontal lesions on the aggressive behaviors in rhesus monkeys. J Comp Physiol Psychol 72: 132-144.
16. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB et al (1989). Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587-599.
17. De La Fuente JM, Goldman S, Stanus E, Vizuete C, Morlan I, Bobes J et al (1997). Brain glucose metabolism in borderline personality disorder. J Psychiat Res 31: 531-541.
18. De La Fuente JM, Lotstra F, Goldman S, Biver F, Luxen A, Bidaut L et al (1994). Temporal glucose metabolism in borderline personality disorder. Psychiatr Res Neuroimag 55: 237-245.
19. First MB, Spitzer RL, Gibbon M, Williams JMG, Benjamin L (1996). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), (Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York.
20. Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA et al (1994). Positron-emission tomography and personality disorders. Neuropsychopharmacology 10: 21-28.
21. Grafman J, Schwab K, Warden D, Pridgen A, Brown HR, Salazar AM (1996). Frontal lobe injuries, violence, and aggression: a report of the Vietnam head injury study. Neurology 46: 1231-1238.
22. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
23. Heinrichs RW (1989). Frontal cerebral lesions and violent incidents in chronic neuropsychiatric patients. Biol Psychiatry 25: 174-178.
24. Juengling FD, Schmahl C, Hesslinger B, Ebert D, Bremner JD, Gostomzyk J et al (2003). Positron emission tomography in female patients with borderline personality disorder. J Psychiat Res 37: 109-115.
25. Koenigsberg HW, Harvey PD, Mitropoulou V, New AS, Goodman M, Silverman J et al (2001). Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? J Pers Disord 15: 358-370.
26. Krebs HA, Cheng LK, Wright GJ (1984). Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr Biomed Appl 310: 412-417.
27. Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S et al (2001). Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 158: 775-782.
28. Malone KM, Corbitt EM, Li S, Mann JJ (1996). Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168: 324-329.
29. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA (1996a). Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153: 174-182.
30. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA (1996b). Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab 16: 418-426.
31. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL et al (1997). Cingulate function in depression: a potential predictor of treatment response. NeuroReport 8: 1057-1061.
32. Mayberg HS, Brannan SK, Tekell JL, Silva A, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48: 830-843.
33. Mayberg HS, Lewis PJ, Regenold W, Wagner HNJ (1994). Paralimbic hypoperfusion in unipolar depression. J Nucl Med 35: 929-934.
34. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675-682.
35. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S et al (2002). The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728-737.
36. Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE (1992). Paralimbic frontal lobe metabolism in depression associated with Huntington's disease. Neurology 42: 1791-1797.
37. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF et al (1990). Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 28: 57-64.
38. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ et al (1989). Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 46: 213-221.
39. McBride PA, Tierney H, DeMeo M, Chen J-S, Mann JJ (1990). Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27: 1143-1155.
40. 2O PET response to intravenous d-fenfluramine. Am J Psychiatry 155: 1241-1246.
41. Miura SA, Schapiro MB, Grady CL, Kumar A, Salerno JA, Kozachuk WE (1990). Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study. Neurosci Res 27: 500-504.
42. Myers JE, Mieczkowski TA, Perel J, Abbondanza DM, Cooper TB, Mann JJ (1994). Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders: correlation with increased serotonergic responsivity. Biol Psychiatry 35: 112-120.
43. New AS, Buchsbaum MS, Hazlett EA, Goodman M, Koenigsberg HW, Lo J et al (2004). Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berlin) 176: 451-458.
44. New AS, Hazlett EA, Koenigsberg H, Platholi J, Silverman J, Siever LJ (2002). Blunted prefrontal cortical 18 fluorodeoxyglucose positron emission tomography response to metachlorophenyl-piperazine in impulsive aggression. Arch Gen Psychiatry 59: 621-629.
45. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, De Montigny C et al (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94: 5308-5313.
46. Oquendo MA, Mann JJ (2000). The biology of impulsivity and suicidality. Psychiatr Clin North Am 23: 11-25.
47. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B et al (2003). Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 60: 14-22.
48. Oxenkrug GF (1979). The content and uptake of 5-HT by blood platelets in depressive patients. J Neural Transm 45: 285-289.
49. Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS (1987). Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. BM Psychiatry 22: 545-553.
50. Raine A, Buchsbaum M, LaCasse L (1997). Brain abnormalities in murderers indicated by positron emission tomography. Biol Psychiatry 42: 495-508.
51. Raleigh MJ, Steklis HD, Ervin FR, Kling AS, McGuire MT (1979). The effects of orbitofrontal lesions on the aggressive behavior of vervet monkeys (Cercopithecus aethiops sabaeus). Exp Neurol 66: 158-168.
52. 18F] fluorodeoxyglucose Positron Emission Tomography. Neuropsychopharm 20: 413-423.
53. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S (1984). Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 34: 1029-1039.
54. Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D (2003). Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 123: 153-163.
55. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM (2000). A fenfluramine-activated FDG-PET Study of Borderline Personality Disorder. Biol Psychiatry 47: 540-547.
56. Spitzer RL, Williams JBW, Gibbon M, First MB (1990). Structured Clinical Interview for DSM-III-R. Patient Edition (SCID-P). American Psychiatric Press: Washington, DC.
57. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Dimensional Proportional System: An Approach to Cerebral Imaging. Thieme Medical Publishers Inc.: NewYork.
58. Volkow ND, Tancredi L (1987). Neural substrates of violent behaviour. A preliminary study with positron emission tomography. Br J Psychiatry 151: 668-673.
59. Woods RP, Cherry SR, Mazziotta JC (1992). Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16: 620-633.
60. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A et al (1998). Axis I comorbidity of borderline personality disorder. Am J Psychiatry 155: 1733-1739.